Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism*; D001665:Binding Sites; D002417:Cattle; D004285:Dogs; D005439:Flufenamic Acid / Q000032:analysis / Q000378:metabolism; D005461:Fluorine / Q000378:metabolism; D006736:Horses; D006801:Humans; D008433:Mathematics; D008528:Mefenamic Acid / Q000032:analysis / Q000378:metabolism; D011485:Protein Binding; D011817:Rabbits; D012709:Serum Albumin / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000378:metabolism; D012756:Sheep; D013045:Species Specificity; D013057:Spectrum Analysis; D013552:Swine; D062367:ortho-Aminobenzoates / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D012709:Serum Albumin; D062367:ortho-Aminobenzoates; D012710:Serum Albumin, Bovine; D005461:Fluorine; D008528:Mefenamic Acid; D005439:Flufenamic Acid